Stotles logo
Awarded

NHS Framework for Midlands and East, Branded Medicines – Tranche A and Annual

Published

Supplier(s)

Allergan, Accord UK Ltd, Roche Products Ltd, Sandoz Ltd, Amgen Ltd, Napp Pharmaceuticals Ltd, Novo Nordisk, Pfizer Ltd, Vifor Pharma UK Ltd, Ipsen, Janssen Cilag Ltd, Teva UK Ltd, Almirall, Merck Serono Limited, Chugai Pharma UK Ltd, Pharmacosmos UK Ltd, Merz, Eli Lilly and Company Ltd, Merck Sharpe and Dohme (UK) Limited, Zentiva Pharma UK Ltd, Thornton and Ross Ltd, Accord UK Ltd, Roche Products Ltd, AstraZeneca, Bristol Myers Squibb, Amgen Ltd, Napp Pharmaceuticals Ltd, Pfizer Ltd, GlaxoSmithKline UK Limited, Janssen Cilag Ltd, Teva UK Ltd, Sobi (Swedish Orphan Biovitrum Ltd), Celltrion Healthcare United Kingdom Ltd, Takeda UK Limited, Aventis Pharma ltd t/a Sanofi, Eli Lilly and Company Ltd, GEDEON RICHTER (UK) LIMITED, Organon Pharmaceuticals UK Ltd, UCB Pharma Ltd

Value

39 GBP

Description

NHS Framework for the Midlands and East, Branded Medicines – Tranche A and Annual Tranche<br/><br/>Offer reference number: CM/PHR/20/5602<br/>CM/PHR/20/5602/01 - NHS Framework for the Midlands and East, Branded Medicines – Tranche A. Period of framework: 1 March 2022 to 29 February 2024 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months<br/>CM/PHR/20/5602/02 - NHS Framework for the Midlands and East Branded Medicines - Annual Tranche Products. Period of framework: 1 March 2022 to 28 February 2023 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months. Lot 1: CM/PHR/20/5602/01 - NHS Framework Mids and East, Branded Medicines–Tranche A CM/PHR/20/5602/01 - NHS Framework for the Midlands and East, Branded Medicines – Tranche A. Period of framework: 1 March 2022 to 29 February 2024 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months Lot 2: CM/PHR/20/5602/02 - NHS Framework Mids and East Branded Medicines - Annual CM/PHR/20/5602/02 - NHS Framework for the Midlands and East Branded Medicines - Annual Tranche Products. Period of framework: 1 March 2022 to 28 February 2023 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months.

Timeline

Award date

2 years ago

Publish date

2 years ago

Buyer information

NHS COMMISSIONING BOARD

Contact:
Collette Patrick
Email:
collette.patrick@nhs.net

Explore contracts and tenders relating to NHS COMMISSIONING BOARD

Go to buyer profile
To save this opportunity, sign up to Stotles for free.
Save in app
  • Looking glass on top of a file iconTender tracking

    Access a feed of government opportunities tailored to you, in one view. Receive email alerts and integrate with your CRM to stay up-to-date.

  • ID card iconProactive prospecting

    Get ahead of competitors by reaching out to key decision-makers within buying organisations directly.

  • Open folder icon360° account briefings

    Create in-depth briefings on buyer organisations based on their historical & upcoming procurement activity.

  • Teamwork iconCollaboration tools

    Streamline sales workflows with team collaboration and communication features, and integrate with your favourite sales tools.

Stop chasing tenders, start getting ahead.

Create your free feed

Explore similar tenders and contracts

Browse open tenders, recent contract awards and upcoming contract expiries that match similar CPV codes.

Explore other contracts published by NHS COMMISSIONING BOARD

Explore more open tenders, recent contract awards and upcoming contract expiries published by NHS COMMISSIONING BOARD.

Explore more suppliers to NHS COMMISSIONING BOARD

Sign up